New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
hopOn Launches Social-First Travel Booking Service and Announces Seed Funding
-
Champions Oncology Announces $14 Million Capital Raise
-
PhaseBio Raises $40 Million Series C Financing Led by AstraZeneca
-
Cortendo Reports Results and Activities for the Fourth Quarter and Full Year 2014
-
TRACON Pharmaceuticals Reports 2014 Year-End Financial Results and Recent Corporate Highlights
-
TRACON Pharmaceuticals Reports 2014 Year-End Financial Results and Recent Corporate Highlights
-
Bypass Mobile Selected to Present at The Montgomery Summit
-
Enterprise Productivity Platform Do Integrates with Microsoft Office 365 and Raises $2M
-
Madison Logic Selected to Present at The Montgomery Summit
-
Scale Computing Selected to Present at The Montgomery Summit
-
Swiftype Raises $13M to Deliver Powerful Search
-
Branch Metrics Wins 2015 GSMA Mobile World Congress Startup Innovation Competition
-
Damballa Selected to Present at The Montgomery Summit
-
Form SC 13D Tracon Pharmaceuticals, Filed by: New Enterprise Associates 14, L.P.
-
Form SC 13G/A Millennial Media Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Form SC 13G/A CVENT INC Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Form SC 13G/A Groupon, Inc. Filed by: New Enterprise Associates 12, Limited Partnership
-
Form SC 13G NEVRO CORP Filed by: New Enterprise Associates 14, L.P.
-
Form SC 13G AEROHIVE NETWORKS, INC Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Form SC 13G Care.com Inc Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Form SC 13G OPOWER, INC. Filed by: New Enterprise Associates 12, Limited Partnership
-
Form SC 13G/A Tableau Software Inc Filed by: NEW ENTERPRISE ASSOCIATES 11 LP
-
Form SC 13G/A BOINGO WIRELESS INC Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
Form 4 Tracon Pharmaceuticals, For: Feb 04 Filed by: New Enterprise Associates 14, L.P.
-
Form SC 13G/A Workday, Inc. Filed by: New Enterprise Associates 12, Limited Partnership
-
Form SC 13G/A FUSION-IO, INC. Filed by: New Enterprise Associates 12, Limited Partnership
-
Form SC 13G/A CHANNELADVISOR CORP Filed by: New Enterprise Associates 12, Limited Partnership
-
TRACON Pharmaceuticals (TCON) Prices 3.6M Common IPO at $10/Share
-
TRACON Pharmaceuticals Announces Pricing of Initial Public Offering
-
Form 4 INTERLEUKIN GENETICS For: Dec 23 Filed by: New Enterprise Associates 14, L.P.
-
Form SC 13D/A ARDELYX, INC. Filed by: New Enterprise Associates 12, Limited Partnership
-
Form SC 13D/A TREVENA INC Filed by: New Enterprise Associates 12, Limited Partnership
-
BioMarin Pharma (BMRN) Updates on Share Percentages in Prosensa (RNA) Deal
-
Form 4 Tableau Software Inc For: Dec 02 Filed by: NEW ENTERPRISE ASSOCIATES 11 LP
-
Ziarco Announces Appointment of Mike Grey to Board of Directors
-
Form 4 CVENT INC For: Nov 25 Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Form SC 13D/A Paratek Pharmaceuticals, Filed by: New Enterprise Associates 12, Limited Partnership
-
Cerulean Pharma Appoints David Parkinson, M.D., to Board of Directors
-
Form SC 13D Dermira, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Form SC 13D Vitae Pharmaceuticals, Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
TRACON Pharmaceuticals Completes $27 Million Financing and Expands Management Team and Board of Directors
-
Form 4 SUNESIS PHARMACEUTICALS For: Aug 27 Filed by: New Enterprise Associates 12, Limited Partnership
-
Form 4 Tableau Software Inc For: Aug 20 Filed by: NEW ENTERPRISE ASSOCIATES 11 LP
-
Form SC 13D/A Epizyme, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Form 4 CVENT INC For: Aug 14 Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Form 4 Epizyme, Inc. For: Aug 14 Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Form SC 13D Loxo Oncology, Inc. Filed by: New Enterprise Associates 14, L.P.
-
Loxo Oncology (LOXO) Prices 5.26M Common IPO at $13/Share
-
Form SC 13D Roka BioScience, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
8x8, Inc. (EGHT) Appoints New Director

